nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Nausea—Goserelin—breast cancer	0.000669	0.000669	CcSEcCtD
Ceftibuten—Dysgeusia—Capecitabine—breast cancer	0.000668	0.000668	CcSEcCtD
Ceftibuten—Dizziness—Vinorelbine—breast cancer	0.000667	0.000667	CcSEcCtD
Ceftibuten—Urticaria—Mitoxantrone—breast cancer	0.000661	0.000661	CcSEcCtD
Ceftibuten—Diarrhoea—Thiotepa—breast cancer	0.000659	0.000659	CcSEcCtD
Ceftibuten—Body temperature increased—Irinotecan—breast cancer	0.000657	0.000657	CcSEcCtD
Ceftibuten—Body temperature increased—Mitoxantrone—breast cancer	0.000657	0.000657	CcSEcCtD
Ceftibuten—Abdominal pain—Mitoxantrone—breast cancer	0.000657	0.000657	CcSEcCtD
Ceftibuten—Abdominal pain—Irinotecan—breast cancer	0.000657	0.000657	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000657	0.000657	CcSEcCtD
Ceftibuten—Pancytopenia—Epirubicin—breast cancer	0.000647	0.000647	CcSEcCtD
Ceftibuten—Anorexia—Paclitaxel—breast cancer	0.000646	0.000646	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000644	0.000644	CcSEcCtD
Ceftibuten—Vomiting—Vinorelbine—breast cancer	0.000641	0.000641	CcSEcCtD
Ceftibuten—Body temperature increased—Gemcitabine—breast cancer	0.00064	0.00064	CcSEcCtD
Ceftibuten—Renal failure—Methotrexate—breast cancer	0.000638	0.000638	CcSEcCtD
Ceftibuten—Dysuria—Epirubicin—breast cancer	0.000637	0.000637	CcSEcCtD
Ceftibuten—Neutropenia—Epirubicin—breast cancer	0.000637	0.000637	CcSEcCtD
Ceftibuten—Dizziness—Thiotepa—breast cancer	0.000637	0.000637	CcSEcCtD
Ceftibuten—Rash—Vinorelbine—breast cancer	0.000636	0.000636	CcSEcCtD
Ceftibuten—Dermatitis—Vinorelbine—breast cancer	0.000635	0.000635	CcSEcCtD
Ceftibuten—Urticaria—Fluorouracil—breast cancer	0.000633	0.000633	CcSEcCtD
Ceftibuten—Headache—Vinorelbine—breast cancer	0.000632	0.000632	CcSEcCtD
Ceftibuten—Body temperature increased—Fluorouracil—breast cancer	0.00063	0.00063	CcSEcCtD
Ceftibuten—Haematuria—Methotrexate—breast cancer	0.000619	0.000619	CcSEcCtD
Ceftibuten—Insomnia—Paclitaxel—breast cancer	0.000613	0.000613	CcSEcCtD
Ceftibuten—Hypersensitivity—Irinotecan—breast cancer	0.000613	0.000613	CcSEcCtD
Ceftibuten—Hypersensitivity—Mitoxantrone—breast cancer	0.000613	0.000613	CcSEcCtD
Ceftibuten—Vomiting—Thiotepa—breast cancer	0.000612	0.000612	CcSEcCtD
Ceftibuten—Convulsion—Docetaxel—breast cancer	0.00061	0.00061	CcSEcCtD
Ceftibuten—Paraesthesia—Paclitaxel—breast cancer	0.000609	0.000609	CcSEcCtD
Ceftibuten—Rash—Thiotepa—breast cancer	0.000607	0.000607	CcSEcCtD
Ceftibuten—Dermatitis—Thiotepa—breast cancer	0.000607	0.000607	CcSEcCtD
Ceftibuten—Agranulocytosis—Methotrexate—breast cancer	0.000606	0.000606	CcSEcCtD
Ceftibuten—Dyspnoea—Paclitaxel—breast cancer	0.000605	0.000605	CcSEcCtD
Ceftibuten—Headache—Thiotepa—breast cancer	0.000603	0.000603	CcSEcCtD
Ceftibuten—Somnolence—Paclitaxel—breast cancer	0.000603	0.000603	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000603	0.000603	CcSEcCtD
Ceftibuten—Pancytopenia—Doxorubicin—breast cancer	0.000599	0.000599	CcSEcCtD
Ceftibuten—Nausea—Vinorelbine—breast cancer	0.000599	0.000599	CcSEcCtD
Ceftibuten—Renal failure—Epirubicin—breast cancer	0.000598	0.000598	CcSEcCtD
Ceftibuten—Dyspepsia—Paclitaxel—breast cancer	0.000597	0.000597	CcSEcCtD
Ceftibuten—Asthenia—Irinotecan—breast cancer	0.000597	0.000597	CcSEcCtD
Ceftibuten—Asthenia—Mitoxantrone—breast cancer	0.000597	0.000597	CcSEcCtD
Ceftibuten—Jaundice—Epirubicin—breast cancer	0.000593	0.000593	CcSEcCtD
Ceftibuten—Dysuria—Doxorubicin—breast cancer	0.00059	0.00059	CcSEcCtD
Ceftibuten—Neutropenia—Doxorubicin—breast cancer	0.00059	0.00059	CcSEcCtD
Ceftibuten—Decreased appetite—Paclitaxel—breast cancer	0.000589	0.000589	CcSEcCtD
Ceftibuten—Hypersensitivity—Fluorouracil—breast cancer	0.000587	0.000587	CcSEcCtD
Ceftibuten—Dry mouth—Docetaxel—breast cancer	0.000586	0.000586	CcSEcCtD
Ceftibuten—Haemoglobin—Methotrexate—breast cancer	0.000586	0.000586	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000585	0.000585	CcSEcCtD
Ceftibuten—Fatigue—Paclitaxel—breast cancer	0.000585	0.000585	CcSEcCtD
Ceftibuten—Haemorrhage—Methotrexate—breast cancer	0.000583	0.000583	CcSEcCtD
Ceftibuten—Asthenia—Gemcitabine—breast cancer	0.000581	0.000581	CcSEcCtD
Ceftibuten—Constipation—Paclitaxel—breast cancer	0.00058	0.00058	CcSEcCtD
Ceftibuten—Haematuria—Epirubicin—breast cancer	0.00058	0.00058	CcSEcCtD
Ceftibuten—Anaphylactic shock—Docetaxel—breast cancer	0.000575	0.000575	CcSEcCtD
Ceftibuten—Pruritus—Gemcitabine—breast cancer	0.000573	0.000573	CcSEcCtD
Ceftibuten—Nausea—Thiotepa—breast cancer	0.000572	0.000572	CcSEcCtD
Ceftibuten—Diarrhoea—Mitoxantrone—breast cancer	0.000569	0.000569	CcSEcCtD
Ceftibuten—Diarrhoea—Irinotecan—breast cancer	0.000569	0.000569	CcSEcCtD
Ceftibuten—Dry mouth—Capecitabine—breast cancer	0.000568	0.000568	CcSEcCtD
Ceftibuten—Agranulocytosis—Epirubicin—breast cancer	0.000567	0.000567	CcSEcCtD
Ceftibuten—Pruritus—Fluorouracil—breast cancer	0.000563	0.000563	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000558	0.000558	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Paclitaxel—breast cancer	0.000555	0.000555	CcSEcCtD
Ceftibuten—Diarrhoea—Gemcitabine—breast cancer	0.000554	0.000554	CcSEcCtD
Ceftibuten—Renal failure—Doxorubicin—breast cancer	0.000553	0.000553	CcSEcCtD
Ceftibuten—Erythema multiforme—Methotrexate—breast cancer	0.000551	0.000551	CcSEcCtD
Ceftibuten—Dizziness—Irinotecan—breast cancer	0.00055	0.00055	CcSEcCtD
Ceftibuten—Haemoglobin—Epirubicin—breast cancer	0.000548	0.000548	CcSEcCtD
Ceftibuten—Jaundice—Doxorubicin—breast cancer	0.000548	0.000548	CcSEcCtD
Ceftibuten—Anorexia—Docetaxel—breast cancer	0.000548	0.000548	CcSEcCtD
Ceftibuten—Haemorrhage—Epirubicin—breast cancer	0.000546	0.000546	CcSEcCtD
Ceftibuten—Diarrhoea—Fluorouracil—breast cancer	0.000545	0.000545	CcSEcCtD
Ceftibuten—Urticaria—Paclitaxel—breast cancer	0.000539	0.000539	CcSEcCtD
Ceftibuten—Haematuria—Doxorubicin—breast cancer	0.000536	0.000536	CcSEcCtD
Ceftibuten—Abdominal pain—Paclitaxel—breast cancer	0.000536	0.000536	CcSEcCtD
Ceftibuten—Body temperature increased—Paclitaxel—breast cancer	0.000536	0.000536	CcSEcCtD
Ceftibuten—Anorexia—Capecitabine—breast cancer	0.00053	0.00053	CcSEcCtD
Ceftibuten—Vomiting—Mitoxantrone—breast cancer	0.000529	0.000529	CcSEcCtD
Ceftibuten—Vomiting—Irinotecan—breast cancer	0.000529	0.000529	CcSEcCtD
Ceftibuten—Dizziness—Fluorouracil—breast cancer	0.000527	0.000527	CcSEcCtD
Ceftibuten—Agranulocytosis—Doxorubicin—breast cancer	0.000525	0.000525	CcSEcCtD
Ceftibuten—Rash—Irinotecan—breast cancer	0.000524	0.000524	CcSEcCtD
Ceftibuten—Rash—Mitoxantrone—breast cancer	0.000524	0.000524	CcSEcCtD
Ceftibuten—Dermatitis—Mitoxantrone—breast cancer	0.000524	0.000524	CcSEcCtD
Ceftibuten—Dermatitis—Irinotecan—breast cancer	0.000524	0.000524	CcSEcCtD
Ceftibuten—Chills—Methotrexate—breast cancer	0.000523	0.000523	CcSEcCtD
Ceftibuten—Headache—Irinotecan—breast cancer	0.000521	0.000521	CcSEcCtD
Ceftibuten—Headache—Mitoxantrone—breast cancer	0.000521	0.000521	CcSEcCtD
Ceftibuten—Insomnia—Docetaxel—breast cancer	0.00052	0.00052	CcSEcCtD
Ceftibuten—Paraesthesia—Docetaxel—breast cancer	0.000516	0.000516	CcSEcCtD
Ceftibuten—Erythema multiforme—Epirubicin—breast cancer	0.000516	0.000516	CcSEcCtD
Ceftibuten—Vomiting—Gemcitabine—breast cancer	0.000515	0.000515	CcSEcCtD
Ceftibuten—Dyspnoea—Docetaxel—breast cancer	0.000512	0.000512	CcSEcCtD
Ceftibuten—Somnolence—Docetaxel—breast cancer	0.000511	0.000511	CcSEcCtD
Ceftibuten—Rash—Gemcitabine—breast cancer	0.000511	0.000511	CcSEcCtD
Ceftibuten—Dermatitis—Gemcitabine—breast cancer	0.00051	0.00051	CcSEcCtD
Ceftibuten—Haemoglobin—Doxorubicin—breast cancer	0.000507	0.000507	CcSEcCtD
Ceftibuten—Headache—Gemcitabine—breast cancer	0.000507	0.000507	CcSEcCtD
Ceftibuten—Vomiting—Fluorouracil—breast cancer	0.000506	0.000506	CcSEcCtD
Ceftibuten—Dyspepsia—Docetaxel—breast cancer	0.000506	0.000506	CcSEcCtD
Ceftibuten—Haemorrhage—Doxorubicin—breast cancer	0.000505	0.000505	CcSEcCtD
Ceftibuten—Insomnia—Capecitabine—breast cancer	0.000503	0.000503	CcSEcCtD
Ceftibuten—Rash—Fluorouracil—breast cancer	0.000502	0.000502	CcSEcCtD
Ceftibuten—Dermatitis—Fluorouracil—breast cancer	0.000502	0.000502	CcSEcCtD
Ceftibuten—Paraesthesia—Capecitabine—breast cancer	0.0005	0.0005	CcSEcCtD
Ceftibuten—Decreased appetite—Docetaxel—breast cancer	0.0005	0.0005	CcSEcCtD
Ceftibuten—Hypersensitivity—Paclitaxel—breast cancer	0.0005	0.0005	CcSEcCtD
Ceftibuten—Headache—Fluorouracil—breast cancer	0.000499	0.000499	CcSEcCtD
Ceftibuten—Dysgeusia—Methotrexate—breast cancer	0.000497	0.000497	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Docetaxel—breast cancer	0.000496	0.000496	CcSEcCtD
Ceftibuten—Dyspnoea—Capecitabine—breast cancer	0.000496	0.000496	CcSEcCtD
Ceftibuten—Fatigue—Docetaxel—breast cancer	0.000496	0.000496	CcSEcCtD
Ceftibuten—Nausea—Mitoxantrone—breast cancer	0.000494	0.000494	CcSEcCtD
Ceftibuten—Nausea—Irinotecan—breast cancer	0.000494	0.000494	CcSEcCtD
Ceftibuten—Constipation—Docetaxel—breast cancer	0.000492	0.000492	CcSEcCtD
Ceftibuten—Dyspepsia—Capecitabine—breast cancer	0.00049	0.00049	CcSEcCtD
Ceftibuten—Chills—Epirubicin—breast cancer	0.00049	0.00049	CcSEcCtD
Ceftibuten—Asthenia—Paclitaxel—breast cancer	0.000487	0.000487	CcSEcCtD
Ceftibuten—Decreased appetite—Capecitabine—breast cancer	0.000484	0.000484	CcSEcCtD
Ceftibuten—Nausea—Gemcitabine—breast cancer	0.000481	0.000481	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Capecitabine—breast cancer	0.00048	0.00048	CcSEcCtD
Ceftibuten—Fatigue—Capecitabine—breast cancer	0.00048	0.00048	CcSEcCtD
Ceftibuten—Pruritus—Paclitaxel—breast cancer	0.00048	0.00048	CcSEcCtD
Ceftibuten—Erythema multiforme—Doxorubicin—breast cancer	0.000477	0.000477	CcSEcCtD
Ceftibuten—Constipation—Capecitabine—breast cancer	0.000476	0.000476	CcSEcCtD
Ceftibuten—Nausea—Fluorouracil—breast cancer	0.000473	0.000473	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Docetaxel—breast cancer	0.00047	0.00047	CcSEcCtD
Ceftibuten—Flatulence—Epirubicin—breast cancer	0.000468	0.000468	CcSEcCtD
Ceftibuten—Dysgeusia—Epirubicin—breast cancer	0.000465	0.000465	CcSEcCtD
Ceftibuten—Diarrhoea—Paclitaxel—breast cancer	0.000464	0.000464	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Capecitabine—breast cancer	0.000455	0.000455	CcSEcCtD
Ceftibuten—Abdominal pain—Docetaxel—breast cancer	0.000454	0.000454	CcSEcCtD
Ceftibuten—Body temperature increased—Docetaxel—breast cancer	0.000454	0.000454	CcSEcCtD
Ceftibuten—Chills—Doxorubicin—breast cancer	0.000453	0.000453	CcSEcCtD
Ceftibuten—Dizziness—Paclitaxel—breast cancer	0.000448	0.000448	CcSEcCtD
Ceftibuten—Urticaria—Capecitabine—breast cancer	0.000442	0.000442	CcSEcCtD
Ceftibuten—Abdominal pain—Capecitabine—breast cancer	0.00044	0.00044	CcSEcCtD
Ceftibuten—Body temperature increased—Capecitabine—breast cancer	0.00044	0.00044	CcSEcCtD
Ceftibuten—Convulsion—Methotrexate—breast cancer	0.00044	0.00044	CcSEcCtD
Ceftibuten—Agitation—Epirubicin—breast cancer	0.000437	0.000437	CcSEcCtD
Ceftibuten—Flatulence—Doxorubicin—breast cancer	0.000433	0.000433	CcSEcCtD
Ceftibuten—Vomiting—Paclitaxel—breast cancer	0.000431	0.000431	CcSEcCtD
Ceftibuten—Dysgeusia—Doxorubicin—breast cancer	0.00043	0.00043	CcSEcCtD
Ceftibuten—Rash—Paclitaxel—breast cancer	0.000428	0.000428	CcSEcCtD
Ceftibuten—Dermatitis—Paclitaxel—breast cancer	0.000427	0.000427	CcSEcCtD
Ceftibuten—Headache—Paclitaxel—breast cancer	0.000425	0.000425	CcSEcCtD
Ceftibuten—Hypersensitivity—Docetaxel—breast cancer	0.000423	0.000423	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methotrexate—breast cancer	0.000414	0.000414	CcSEcCtD
Ceftibuten—Asthenia—Docetaxel—breast cancer	0.000412	0.000412	CcSEcCtD
Ceftibuten—Convulsion—Epirubicin—breast cancer	0.000412	0.000412	CcSEcCtD
Ceftibuten—Hypersensitivity—Capecitabine—breast cancer	0.00041	0.00041	CcSEcCtD
Ceftibuten—Pruritus—Docetaxel—breast cancer	0.000407	0.000407	CcSEcCtD
Ceftibuten—Agitation—Doxorubicin—breast cancer	0.000404	0.000404	CcSEcCtD
Ceftibuten—Nausea—Paclitaxel—breast cancer	0.000403	0.000403	CcSEcCtD
Ceftibuten—Asthenia—Capecitabine—breast cancer	0.000399	0.000399	CcSEcCtD
Ceftibuten—Dry mouth—Epirubicin—breast cancer	0.000396	0.000396	CcSEcCtD
Ceftibuten—Anorexia—Methotrexate—breast cancer	0.000395	0.000395	CcSEcCtD
Ceftibuten—Pruritus—Capecitabine—breast cancer	0.000394	0.000394	CcSEcCtD
Ceftibuten—Diarrhoea—Docetaxel—breast cancer	0.000393	0.000393	CcSEcCtD
Ceftibuten—Anaphylactic shock—Epirubicin—breast cancer	0.000388	0.000388	CcSEcCtD
Ceftibuten—Convulsion—Doxorubicin—breast cancer	0.000381	0.000381	CcSEcCtD
Ceftibuten—Diarrhoea—Capecitabine—breast cancer	0.000381	0.000381	CcSEcCtD
Ceftibuten—Dizziness—Docetaxel—breast cancer	0.00038	0.00038	CcSEcCtD
Ceftibuten—Insomnia—Methotrexate—breast cancer	0.000375	0.000375	CcSEcCtD
Ceftibuten—Paraesthesia—Methotrexate—breast cancer	0.000372	0.000372	CcSEcCtD
Ceftibuten—Anorexia—Epirubicin—breast cancer	0.00037	0.00037	CcSEcCtD
Ceftibuten—Dyspnoea—Methotrexate—breast cancer	0.000369	0.000369	CcSEcCtD
Ceftibuten—Somnolence—Methotrexate—breast cancer	0.000368	0.000368	CcSEcCtD
Ceftibuten—Dizziness—Capecitabine—breast cancer	0.000368	0.000368	CcSEcCtD
Ceftibuten—Dry mouth—Doxorubicin—breast cancer	0.000366	0.000366	CcSEcCtD
Ceftibuten—Vomiting—Docetaxel—breast cancer	0.000365	0.000365	CcSEcCtD
Ceftibuten—Dyspepsia—Methotrexate—breast cancer	0.000365	0.000365	CcSEcCtD
Ceftibuten—Rash—Docetaxel—breast cancer	0.000362	0.000362	CcSEcCtD
Ceftibuten—Dermatitis—Docetaxel—breast cancer	0.000362	0.000362	CcSEcCtD
Ceftibuten—Decreased appetite—Methotrexate—breast cancer	0.00036	0.00036	CcSEcCtD
Ceftibuten—Headache—Docetaxel—breast cancer	0.00036	0.00036	CcSEcCtD
Ceftibuten—Anaphylactic shock—Doxorubicin—breast cancer	0.000359	0.000359	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Methotrexate—breast cancer	0.000358	0.000358	CcSEcCtD
Ceftibuten—Fatigue—Methotrexate—breast cancer	0.000357	0.000357	CcSEcCtD
Ceftibuten—Vomiting—Capecitabine—breast cancer	0.000354	0.000354	CcSEcCtD
Ceftibuten—Rash—Capecitabine—breast cancer	0.000351	0.000351	CcSEcCtD
Ceftibuten—Insomnia—Epirubicin—breast cancer	0.000351	0.000351	CcSEcCtD
Ceftibuten—Dermatitis—Capecitabine—breast cancer	0.000351	0.000351	CcSEcCtD
Ceftibuten—Headache—Capecitabine—breast cancer	0.000349	0.000349	CcSEcCtD
Ceftibuten—Paraesthesia—Epirubicin—breast cancer	0.000348	0.000348	CcSEcCtD
Ceftibuten—Dyspnoea—Epirubicin—breast cancer	0.000346	0.000346	CcSEcCtD
Ceftibuten—Somnolence—Epirubicin—breast cancer	0.000345	0.000345	CcSEcCtD
Ceftibuten—Anorexia—Doxorubicin—breast cancer	0.000342	0.000342	CcSEcCtD
Ceftibuten—Nausea—Docetaxel—breast cancer	0.000341	0.000341	CcSEcCtD
Ceftibuten—Dyspepsia—Epirubicin—breast cancer	0.000341	0.000341	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methotrexate—breast cancer	0.000339	0.000339	CcSEcCtD
Ceftibuten—Decreased appetite—Epirubicin—breast cancer	0.000337	0.000337	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Epirubicin—breast cancer	0.000335	0.000335	CcSEcCtD
Ceftibuten—Fatigue—Epirubicin—breast cancer	0.000334	0.000334	CcSEcCtD
Ceftibuten—Constipation—Epirubicin—breast cancer	0.000332	0.000332	CcSEcCtD
Ceftibuten—Nausea—Capecitabine—breast cancer	0.000331	0.000331	CcSEcCtD
Ceftibuten—Urticaria—Methotrexate—breast cancer	0.000329	0.000329	CcSEcCtD
Ceftibuten—Abdominal pain—Methotrexate—breast cancer	0.000327	0.000327	CcSEcCtD
Ceftibuten—Body temperature increased—Methotrexate—breast cancer	0.000327	0.000327	CcSEcCtD
Ceftibuten—Insomnia—Doxorubicin—breast cancer	0.000324	0.000324	CcSEcCtD
Ceftibuten—Paraesthesia—Doxorubicin—breast cancer	0.000322	0.000322	CcSEcCtD
Ceftibuten—Dyspnoea—Doxorubicin—breast cancer	0.00032	0.00032	CcSEcCtD
Ceftibuten—Somnolence—Doxorubicin—breast cancer	0.000319	0.000319	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Epirubicin—breast cancer	0.000317	0.000317	CcSEcCtD
Ceftibuten—Dyspepsia—Doxorubicin—breast cancer	0.000316	0.000316	CcSEcCtD
Ceftibuten—Decreased appetite—Doxorubicin—breast cancer	0.000312	0.000312	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Doxorubicin—breast cancer	0.00031	0.00031	CcSEcCtD
Ceftibuten—Fatigue—Doxorubicin—breast cancer	0.000309	0.000309	CcSEcCtD
Ceftibuten—Urticaria—Epirubicin—breast cancer	0.000308	0.000308	CcSEcCtD
Ceftibuten—Constipation—Doxorubicin—breast cancer	0.000307	0.000307	CcSEcCtD
Ceftibuten—Body temperature increased—Epirubicin—breast cancer	0.000306	0.000306	CcSEcCtD
Ceftibuten—Abdominal pain—Epirubicin—breast cancer	0.000306	0.000306	CcSEcCtD
Ceftibuten—Hypersensitivity—Methotrexate—breast cancer	0.000305	0.000305	CcSEcCtD
Ceftibuten—Asthenia—Methotrexate—breast cancer	0.000297	0.000297	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Doxorubicin—breast cancer	0.000293	0.000293	CcSEcCtD
Ceftibuten—Pruritus—Methotrexate—breast cancer	0.000293	0.000293	CcSEcCtD
Ceftibuten—Hypersensitivity—Epirubicin—breast cancer	0.000286	0.000286	CcSEcCtD
Ceftibuten—Urticaria—Doxorubicin—breast cancer	0.000285	0.000285	CcSEcCtD
Ceftibuten—Abdominal pain—Doxorubicin—breast cancer	0.000284	0.000284	CcSEcCtD
Ceftibuten—Body temperature increased—Doxorubicin—breast cancer	0.000284	0.000284	CcSEcCtD
Ceftibuten—Diarrhoea—Methotrexate—breast cancer	0.000283	0.000283	CcSEcCtD
Ceftibuten—Asthenia—Epirubicin—breast cancer	0.000278	0.000278	CcSEcCtD
Ceftibuten—Pruritus—Epirubicin—breast cancer	0.000274	0.000274	CcSEcCtD
Ceftibuten—Dizziness—Methotrexate—breast cancer	0.000274	0.000274	CcSEcCtD
Ceftibuten—Diarrhoea—Epirubicin—breast cancer	0.000265	0.000265	CcSEcCtD
Ceftibuten—Hypersensitivity—Doxorubicin—breast cancer	0.000264	0.000264	CcSEcCtD
Ceftibuten—Vomiting—Methotrexate—breast cancer	0.000263	0.000263	CcSEcCtD
Ceftibuten—Rash—Methotrexate—breast cancer	0.000261	0.000261	CcSEcCtD
Ceftibuten—Dermatitis—Methotrexate—breast cancer	0.000261	0.000261	CcSEcCtD
Ceftibuten—Headache—Methotrexate—breast cancer	0.00026	0.00026	CcSEcCtD
Ceftibuten—Asthenia—Doxorubicin—breast cancer	0.000257	0.000257	CcSEcCtD
Ceftibuten—Dizziness—Epirubicin—breast cancer	0.000256	0.000256	CcSEcCtD
Ceftibuten—Pruritus—Doxorubicin—breast cancer	0.000254	0.000254	CcSEcCtD
Ceftibuten—Vomiting—Epirubicin—breast cancer	0.000246	0.000246	CcSEcCtD
Ceftibuten—Nausea—Methotrexate—breast cancer	0.000246	0.000246	CcSEcCtD
Ceftibuten—Diarrhoea—Doxorubicin—breast cancer	0.000245	0.000245	CcSEcCtD
Ceftibuten—Rash—Epirubicin—breast cancer	0.000244	0.000244	CcSEcCtD
Ceftibuten—Dermatitis—Epirubicin—breast cancer	0.000244	0.000244	CcSEcCtD
Ceftibuten—Headache—Epirubicin—breast cancer	0.000243	0.000243	CcSEcCtD
Ceftibuten—Dizziness—Doxorubicin—breast cancer	0.000237	0.000237	CcSEcCtD
Ceftibuten—Nausea—Epirubicin—breast cancer	0.00023	0.00023	CcSEcCtD
Ceftibuten—Vomiting—Doxorubicin—breast cancer	0.000228	0.000228	CcSEcCtD
Ceftibuten—Rash—Doxorubicin—breast cancer	0.000226	0.000226	CcSEcCtD
Ceftibuten—Dermatitis—Doxorubicin—breast cancer	0.000226	0.000226	CcSEcCtD
Ceftibuten—Headache—Doxorubicin—breast cancer	0.000225	0.000225	CcSEcCtD
Ceftibuten—Nausea—Doxorubicin—breast cancer	0.000213	0.000213	CcSEcCtD
